Psychedelics: Difference between revisions
From BurnZero
mNo edit summary |
|||
| Line 71: | Line 71: | ||
== Long Term Effects == | == Long Term Effects == | ||
<div class="res-img">[[File: | <div class="res-img">[[File:Psychedelic journey preparation.jpg|alt=Cognitive Dissonance|center|Cognitive dissonance quote]]</div> | ||
[[File:Psychedelics relative harm.jpg|alt=Economist relative harm|thumb|'''Figure 3'''. Relative harm of drugs<ref>'''Drug harms in the UK''': a multicriteria decision analysis Prof David J Nutt, FMedSci, Leslie A King, PhD, Lawrence D Phillips, PhD on behalf of the Independent Scientific Committee on Drugs Published:November 01, 2010. DOI:https://doi.org/10.1016/S0140-6736(10)61462-6</ref>.]] | [[File:Psychedelics relative harm.jpg|alt=Economist relative harm|thumb|'''Figure 3'''. Relative harm of drugs<ref>'''Drug harms in the UK''': a multicriteria decision analysis Prof David J Nutt, FMedSci, Leslie A King, PhD, Lawrence D Phillips, PhD on behalf of the Independent Scientific Committee on Drugs Published:November 01, 2010. DOI:https://doi.org/10.1016/S0140-6736(10)61462-6</ref>.]] | ||
Like all medicines, psychedelics are not without potential harm. However, relative to all other drugs (See '''Figure 3''') risk associated with their use is minimal. In a clinical sense, under specific [[priming]], [[setting]] and [[integration]] there is abundant evidence for the safety and efficacy for their use in the treatment of: | Like all medicines, psychedelics are not without potential harm. However, relative to all other drugs (See '''Figure 3''') risk associated with their use is minimal. In a clinical sense, under specific [[priming]], [[setting]] and [[integration]] there is abundant evidence for the safety and efficacy for their use in the treatment of: | ||